Xylem (XYL) to Release Quarterly Earnings on Thursday

Xylem (NYSE:XYL) will post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Xylem to post earnings of $0.84 per share for the quarter. Xylem has set its FY 2024 guidance at 4.000-4.200 EPS.Investors interested in listening to the company’s conference call can do so using this link.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The firm had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.05 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The company’s revenue was up 40.6% on a year-over-year basis. On average, analysts expect Xylem to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Xylem Trading Up 0.2 %

Shares of Xylem stock opened at $132.60 on Tuesday. The company’s 50-day moving average price is $127.91 and its 200-day moving average price is $114.34. The company has a market cap of $32.14 billion, a price-to-earnings ratio of 48.75, a PEG ratio of 2.64 and a beta of 1.10. Xylem has a 12-month low of $87.59 and a 12-month high of $133.34. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were paid a $0.36 dividend. The ex-dividend date was Tuesday, February 20th. This is a boost from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a yield of 1.09%. Xylem’s dividend payout ratio is currently 52.94%.

Insider Buying and Selling at Xylem

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

XYL has been the topic of several research analyst reports. Stifel Nicolaus upped their price target on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Robert W. Baird raised their price target on Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a report on Thursday, March 21st. Royal Bank of Canada lifted their price target on Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 7th. BNP Paribas began coverage on shares of Xylem in a research report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price objective on the stock. Finally, Oppenheimer lifted their target price on shares of Xylem from $133.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, April 18th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $138.11.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.